Human neural tube defects: Genetic causes and prevention

BioFactors

Volumn 37, Issue 4, 2011, Pages 261-268

  de Marco, Patrizia ^a   Merello, Elisa ^a   Cama, Armando ^a   Kibar, Zoha ^b   Capra, Valeria ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Folate; Inositol; Neural tube defects; Planar cell polarity; Prevention

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; CARBAMAZEPINE; COBALAMIN DERIVATIVE; CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; FOLATE RECEPTOR; FOLIC ACID; FOLYLPOLY GAMMA GLUTAMATE CARBOXYPEPTIDASE; FUMONISIN; GLYCINE HYDROXYMETHYLTRANSFERASE; INOSITOL; METHIONE SYNTHASE REDUCTASE; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; PEPTIDE HYDROLASE; PROTEIN; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE; TRANCOBALAMIN; TRANSFERASE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VALPROIC ACID; VANGL1 PROTEIN; VANGL2 PROTEIN; WNT PROTEIN;

ABSENCE OF SIDE EFFECTS; AUTISM; BREAST CANCER; CELL POLARITY; COLON CANCER; DIETARY INTAKE; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GASTRULATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HYPERGLYCEMIA; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY DISTRESS; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPINA BIFIDA;

ANIMALS; CARRIER PROTEINS; CELL POLARITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEURAL TUBE DEFECTS; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA; VERTEBRATA;

EID: 80052030805     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.170     Document Type: Review

References (85)

1. EUROCAT Working Group. (2002) Surveillance of congenital anomalies in Europe 1980-1999. EUROCAT, University of Ulster, Report No. 8.
2. Busby, A., Abramsky, L., Dolk, H., Armstrong, B., Addor, M. C., Anneren, G., Armstrong, N., Baguette, A., Barisic, I., Berghold, A., Bianca, S., Braz, P., Calzolari, E., Christiansen, M., Cocchi, G., Daltveit, A. K., De Walle, H., Edwards, G., Gatt, M., Gener, B., Gillerot, Y., Gjergja, R., Goujard, J., Haeusler, M., Latos-Bielenska, A., McDonnell, R., Neville, A., Olars, B., Portillo, I., Ritvanen, A., Robert-Gnansia, E., Rösch, C., Scarano, G., and Steinbicker, V (2005) Preventing neural tube defects in Europe: a missed opportunity. Repro. Toxic. 20, 393-402.
3. Colas, J. F. and Schoenwolf, G. C. (2001) Towards a cellular and molecular understanding of neurulation. Dev. Dyn. 221, 117-145.
4. Copp, A. J., Greene, N. D. E., and Murdoch, J. N. (2003) The genetic basis of mammalian neurulation. Nat. Rev. Genet. 4, 784-793.
5. van Allen, M. I., Kalousek, D. K., Chernoff, G. F., Juroff, D., Harris, M., McGillivray, B. C., Young, S. L., Langlois, S., MacLeod, P. M., Chitayat, D., Freidman, J. M., Wilson, D., Mcfadden, D., Pantzar, J., Ritchie, S., and Hall, J. G. (1993) Evidence for multi-site closure of the neural tube in humans. Am. J. Med. Genet. 47, 723-743.
6. Rossi, A., Cama, A., Piatelli, G., Ravegnani, M., Biancheri, R., and Tortori-Donati P. (2004) Spinal dysraphism: MR imaging rationale. J. Neuroradiol. 31, 3-24.
7. Wald, N. J., Cuckle, H., Brock, J. H., Peto, R., Polani, P. E., and Woodford F. P. (1977) Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1, 1323-1332.
8. Hirose, S.; Farmer, D. L., and Albanese, C. T. (2001) Fetal surgery for myelomeningocele. Curr. Opin. Obstet. Gynecol. 13, 215-522.
9. Sutton, L. N. (2008) Fetal surgery for neural tube defects. Best. Pract. Res. Clin. Obstet. Gynaecol. 22, 175-188.
10. Moretti, M. E., Bar-Oz, B., Fried, S., and Koren, G. (2005) Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 16, 216-219.
11. Loeken, M. R. (2005) Current perspectives on the causes of Neural Tube Defects resulting from diabetic pregnancy. Am. J. Med. Genet. Part C 135C, 77-87.
12. Shaw, G. M., Ouach, T., Nelson, V., Carmichael, S. L., Schaffer, D. M., Selvin, S., and Yang, W. (2003) Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am. J. Clin. Nutr. 78, 972-978.
13. Shaw, G. M., Velie, E. M., and Schaffer, D. (1996) Risk of neural tube defect-affected pregnancies among obese women. JAMA 275, 1093-1096.
14. Wasserman, C. R., Shaw, G. M., Selvin, S., Gould, J. B., and Syme, S. L. (1998) Socioeconomic status, neighborhood social conditions, and neural tube defects. Am. J. Public Health. 88, 1674-1680.
15. Matalon, S., Schechtman, S., Goldzweig, G., and Ornoy, A. (2002) The teratogenic effect of carbamazepine: A meta-analysis of 1255 exposures. Reprod. Toxicol. 5, 33-39.
16. Myrianthopoulos, N. C. and Melnick, M. (1987) Studies in neural tube defects. I. Epidemiological and etiologic aspects. Am. J. Med. Genet. 26, 783-796.
17. Correa, A., Stolley, A., and Liu, Y. (2000) Prenatal tea consumption and risks of anencephaly and spina bifida. Ann. Epidemiol. 10, 476-477.
18. Sever, L. E. (1995) Looking for causes of neural tube defects: were does the environment fit in? Environ. Health Perspect. 103, 165-171.
19. Whiteman, D., Murphy, M., Hey, K., O'Donnell, M., and Goldacre, M. (2000) Reproductive factors, subfertility, and risk of neural tube defects: a case-control study based on the Oxford Record Linkage Study Register. Am. J. Epidemiol. 152, 823-828.
20. Schmidt, R. J., Romitti, P. A., Burns, T. L., Browne, M. L.; Drushel, C. M., Oln, R. S.; Birth Defects Prevention Study. (2009) Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res. Part A: Clin. Mol. Teratol. 85, 879-889.
21. De Marco, P., Merello, E., Calevo, M. G., Mascelli, S., Pastorino, D., Crocetti, L., De Biasio, P., Piatelli, G., Cama, A., and Capra, V. (2011) Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study. Childs Nerv. Syst. Jan 5. [Epub ahead of print].
22. Partington, M. D. and McLone, D. G. (1995) Hereditary factors in the etiology of neural tube defects. Results of a survey. Pediatr. Neurosurg. 23, 311-316.
23. Risch, N. (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am. J. Hum. Genet. 46, 229-241.
24. Byrne, J. and Carolan, S. (2006) Adverse reproductive outcomes among pregnancies of aunts and (spouses of) uncles in Irish families with neural tube defects. Am. J. Med. Genet. A 140, 52-61.
25. Medical Research Council Vitamin Study Research Group. (1991) Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338, 131-137.
26. Czeizel, A. E. and Dudas, I. (1992) Prevention of the first occurence of neural-tube defects by periconceptional vitamin supllementation. N. Engl. J. Med. 327, 1832-1835.
27. Institute of Medicine. (1998) Food and Nutrition Board. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press, Washington, DC.
28. Canfield, M. A., Collins, J. S., Botto, L. D., Williams, L. J., Mai, C. T., Kirby, R. S., Pearson, K., Devine, O., Mulinare, J.; National Birth Defects Prevention Network. (2005). Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res. A Clin. Mol. Teratol. 73, 679-89.
29. De Wals, P., Tairou, F., Van Allen, M. I., Uh, S. H., Lowry, R. B., Sibbald, B., Evans, J. A., Van den Hof, M. C., Zimmer, P., Crowley, M., Fernandez, B., Lee, N. S., and Niyonsenga, T. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 12, (357): 135-142.
30. Sayed, A. R., Bourne, D., Pattinson, R., Nixon, J., and Henderson, B. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its costbenefit in South Africa. Birth Defects Res. A Clin. Mol. Teratol. 82, 211-216.
31. Lopez-Camelo, J. S., Castilla, E. E., and Orioli, I. M. 2010. Folic acid flour fortification: Impact on the frequencies of 52 congenital anomaly types in three South American countries. Am. J. Med. Genet. Part A 152A: 2444-2458.
32. Johansson, M.; Appleby, P. N.; Allen, N. E.; Travis, R. C.; Roddam, A. W.; Egevad, L.; Jenab, M.; Rinaldi, S., Kiemeney, L. A., Bueno-de-Mesquita, H. B., Vollset, S. E., Ueland, P. M., Sánchez, M. J., Quirós, J. R., González, C. A., Larrañaga, N., Chirlaque, M. D., Ardanaz, E., Sieri, S., Palli, D., Vineis, P., Tumino, R., Linseisen, J., Kaaks, R., Boeing, H., Pischon, T., Psaltopoulou, T., Trichopoulou, A., Trichopoulos, D., Khaw, K. T., Bingham, S., Hallmans, G., Riboli, E., Stattin, P., and Key, T. J. (2008). Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol. Biomarkers Prev. 17, 279-285.
33. Giovannucci, E., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Fuchs, C., Rosner, B. A., Speizer, F. E., and Willett, W. C. (1998). Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann. Intern. Med. 129, 517-524.
34. Sanjoaquin, M. A., Allen, N., Couto, E., Roddam, A. W., and Key, T. J. (2005). Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer 113, 825-828.
35. Kim, Y. I. (2006). Does a high folate intake increase the risk of breast cancer? Nutr. Rev. 64, 468-475.
36. Mills, J. L., Scott, J. M., Kirke, P. N., McPartlin, J. M., Conley, M. R., Weir, D. G., Molloy, A. M., and Lee, Y. J. (1996) Homocysteine and neural tube defects. J. Nutr. 126, 756S-760S.
37. Scott, J. M. (1999) Folate and vitamin B12. Proc. Nutr. Soc. 58, 441-448.
38. van der Put, N. M., van Straaten, H. W., Trijbels, F. J., and Blom, H. J. Folate, homocysteine and neural tube defects: an overview. Exp. Biol. Med. 2001 226, 243-270.
39. Van der Put, N. M., Steegers-Theunissen, R. P., Frosst, P., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., Mariman, E. C., den Heyer, M., Rozen, R., Blom, H. J. (1995) Mutated methylenetetrahydrofolate reductase as risk factor for spina bifida. Lancet 346, 1070-1071.
40. Ou, C. Y., Stevenson, R. E., Brown, V. K., Schwart, C. E., Allen, W. P., Khoury, M. J., Rozen, R., Oakley, G. P., and Adams, M. J. (1996) Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet. 63, 610-614.
41. Christensen, B., Arbour, L., Tran, P., Leclerc, D., Sabbaghian, N., Platt, R., Gilfix, B. M., Rosenblatt, D. S., Gravel, R. A., Forbes, P., and Rozen, R. (1999) Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet. 84, 151-157.
42. Koch, M. C., Stegmann, K., Ziegler, A., Schroter, B., Ermert, A. (1998) Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur. J. Pediatr. 157, 487-492.
43. Gonzales-Herrera, L., Garcia-Escalante, G., Castillo-Zapata, I., Canto-Herrera, J., Caballos-Quintal, J., Pinto-Escalante, D., Diaz-Rubio, F., Del Angel, R. M., and Orozco-Orozco, L. (2002) Frequency of the thermolabile vatiant C677T in the MTHFR gene and lack of association with neural tube defects in the State of Yucatan, Mexico. Clin Genet 62, 394-398.
44. Revilla, J. I. G., Hernandez, F. N., Martin, M. T. C., Salvador, M. T., and Romero, J. G. (2003) C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population. Med. Clin. 120, 441-445.
45. Botto, L. D. and Yang, Q. (2000) 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151, 862-877.
46. van der Put, N. M., Gabreels, F., Stevens, E. M., Smeitink, J. A., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., and Blom, H. J. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62, 1044-1051.
47. Weisberg, I., Tran, P., Christensen, B, Sibani, S., and Rozen, R. (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 6, 169-172.
48. De Marco, P., Calevo, M. G., Moroni, A., Arata, L., Merello, E., Finnell, R. H., Zhu, H., Andreussi, L., Cama, A., Capra, V. (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J. Hum. Genet. 47, 319-324.
49. Brody, L. C., Conley, M., Cox, C., Kirke, P. N., McKeever, M. P., Mills, J. L., Molloy, A. M., O'Leary, V. B., Parle-McDermott, A., Scott, J. M., and Swanson, D. A. (2002) A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the birth defects research group. Am. J. Hum. Genet. 71, 1207-1215.
50. O'Leary, V. B., Mills, J. L., Pangilinan, F., Kirke, P. N., Cox, C., Conley, M., Weiler, A., Peng, K., Shane, B., Scot, t J. M., Parle-McDermott, A., Molloy, A. M., Brody, L. C.; Members of the Birth Defects Research Group (2005) Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol. Genet. Metab. 85, 220-227.
51. Rothenberg, S. P., da Costa, M. P., Sequeira, J. M., Cracco, J., Roberts, J. L., Weedon, J., and Quadros, E. V. (2004) Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N. Engl. J. Med. 350, 134-142.
52. Cavalli, P. and Copp, A. J. (2002) Inositol and folate resistant neural tube defects. J Med Genet. 39, E5.
53. Fleming, A. and Copp, A. J. (1998) Embryonic folate metabolism and mouse neural tube defects. Science 280, 2107-2109.
54. Barbera, J. P., Rodriguez, T. A., Greene, N. D., Weninger, W. J., Simeone, A., Copp, A. J., Beddington, R. S., and Dunwoodie, S. (2002) Folic acid prevents exencephaly in Cited2 deficient mice. Hum. Mol. Genet. 11, 283-293.
55. Green, N. D. and Copp, A. J. (1997). Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3, 60-66.
56. Cogram, P., Hynes, A., Dunlevy, L. P.E, Greene, N. D., and Copp, A. J. (2004) Specific forms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol. Hum. Mol. Genet. 13, 7-14.
57. Van Straaten, H. W. M, and Copp, A. J. (2001) Curly tail: a 50-year history of the mouse spina bifida model. Anat. Embryol. 203, 225-237.
58. Cogram, P., Tesh, S., Tesh, J., Wade, A., Allan, G., Greene, N. D., and Copp, A. J. (2002) D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects. Hum. Reprod. 17, 2451-2458.
59. Seller, M. J. (1994) In Neural Tube Defects (Ciba Foundation Symposium 181). (Bock, G. and Marsh, J. eds.). pp. 161-173. Wiley, Chichester.
60. Copp, A. J., Brook, F. A. and Roberts, H. J. (1988) A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. Development 104, 285-295.
61. Reece, E. A., Khandelwal, M., Wu, Y. K., and Borenstein, M. (1997) Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. Am. J. Obstet. Gynecol. 176, 536-539.
62. Benjamin, J., Levine, J., Fux, M., Aviv, A., Levy, D., and Belmaker, R. H. (1995) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am. J. Psychiatry 152, 1084-1086.
63. Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., and Allan, G. (1999) Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N. Engl. J. Med. 340, 1314-1320.
64. Kontoangelos, K., Vaidakis, N., Zervas, I., Thomadaki, O., Christaki, S., Stavrianeas, N. G., and Papadimitriou, G. N. (2010) Administration of inositol to a patient with bipolar disorder and psoriasis: a case report. Cases J. 23, 69.
65. Levine, J., Aviram, A., Holan, A., Ring, A., Barak, Y., and Belmaker, R. H. (1997) Inositol treatment of autism. J. Neural. Transm. 104, 307-310.
66. Howlett, A. and Ohlsson, A. (2003) Inositol for respiratory distress syndrome in preterm infants. Cochrane Database syst Rev 4, CD000366.
67. Cavalli, P., Tedoldi, S., and Riboli, B. (2008) Inositol supplementation in pregnancies at risk of apparently folate-resistant NTDs. Birth Defects Res. A Clin. Mol. Teratol. 82, 540-542.
68. Wallingford, J. B. and Harland, R. M. (2002) Neural tube closure requires Dishevelled-dependent convergent extension of the midline. Development 129, 5815-5825.
69. Keller, R. (2002) Shaping the vertebrate body plan by polarized embryonic cell movements. Science 298, 1950-1954.
70. Strutt, H. and Strutt, D. (2005) Longrange coordination of planar polarity in Drosophila. Bioessays 27, 1218-1227.
71. Vinson, C. R. and Adler, P. N. (1987) Directional non-cell autonomy and transmission of polarity information by the frizzled gene of Drosophila. Nature 329, 549-551.
72. Wolff, T. and Rubin, G. M. (1998) Strabismus, a novel gene that regulates tissue polarity and cell fate deicisions in Drosophila. Development 125, 1149-1159.
73. Heisenberg, C. P. (2002) Wnt signalling: Refocusing on Strabismus. Curr. Biol. 12, R657-R659.
74. Usui, T., Shima, Y., Shimada, Y., Hirano, S., Burgess, R. W., Scharz, T. L., Takeichi, M., and Uemura, T. (1999) Flamingo, a seven-pass transmembrane cadherin, regulates planar cell polarity under the control of Frizzled. Cell 98, 585-595.
75. Axelrod, J. D., Miller, J. R., Shulman, J. M., Moon, R. T., and Perrimon, N. L. (1998) Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and wingless signaling pathways. Genes Dev. 12, 2610-2622.
76. Gubb, D., Green, C., Huen, D., Coulson, D., Johnson, G., Tree, D., Collier, S., and Roote, J. (1999) The balance between isoforms of the Prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev. 13, 2315-2327.
77. Feiguin, F., Hannus, M., Mlodzik, M., and Eaton, S. (2001) The ankyrin repeat protein Diego mediates Frizzled-dependent planar polarization. Dev. Cell. 1, 93-101.
78. Wang, Y. and Nathans, J. (2007) Tissue/planar cell polarity in vertebrates: new insights and new questions. Development 134, 647-658.
79. Kibar, Z., Vogan, K. J., Groulx, N., Groulx, N., Justice, M. J., Underhill, D. A., and Gros, P. (2001) Ltap, a mammalian homolog of Drosophila Strabismus/Van Gogh, is altered in the mouse neural tube mutant Loop-tail. Nat. Genet. 28, 251-255.
80. Katoh, M. and Katoh, M. (2005) Identification and characterization of rat Ankrd6 gene in silico. Int. J. Mol. Med. 15, 359-363.
81. Kibar, Z., Torban, E., Mc Dearmid, J. R., Reynolds, A., Mathieu, M., Kirillova, I., De Marco, P., Merello, E., Hayes, J. M., Wallingford, J. B., Drapeau, P., Capra, V., and Gros, P. (2007) Mutations in VANGL1 associated in neural-tube defects. N. Engl. J. Med. 361, 1432-1437.
82. Kibar, Z., Bosoi, C. M., Kooistra, M., Salem, S., Finnell, R. H., De Marco, P., Merello, E., Bassuk, A. G., Capra, V., and Gros, P. (2009) Novel mutations in VANGL1 in neural tube defects. Hum. Mutat. 30, E706-E715.
83. Reynolds, A., McDearmid, J. R., Lachance, S., De Marco, P., Merello, E., Capra, V., Gros, P., Drapeau, P., and Kibar, Z. (2010) VANGL1 rare variants associated with neural tube defects affect convergent extension in zebrafish. Mech. Dev. 127, 385-392.
84. Kibar, Z., Salem, S., Bosoi, C. M., Pauwels, E., De Marco, P., Merello, E., Bassuk, A. G., Capra, V., and Gros, P. (2010) Contribution of VANGL2 mutations to isolated neural tube defects. Clin. Genet. Jan 5. [Epub ahead of print].
85. Lei, Y. P., Zhang, T., Li, H., Wu, B. L., Jin, L., and Wang, H. Y. (2010) VANGL2 mutations in human cranial neural-tube defects N. Engl. J.Med. 362, 2232-2235.